Considering the needs of those affected.
People with overweight and obesity differ – not only in their weight and health status but also in their everyday lives and individual needs.
formoline L112 EXTRA supports them all –
whether during weight reduction or in maintaining the weight they have achieved.
Post‑GLP‑1 therapy with formoline L112 EXTRA
Sabine (52) increasingly feels how her weight is limiting her everyday life — whether during physical activity, at work or in social situations. She would like to improve her quality of life and is looking for a sustainable approach that helps her become more active and feel more vital. She views weight‑loss injections as a supportive measure that she combines with a healthy lifestyle. Medical supervision is very important to her. However, she is unsure how long she will be able to finance GLP‑1 therapy privately and is concerned about experiencing a yo‑yo effect.
Post‑GLP‑1 therapy with formoline L112 EXTRA
Laura (33) is career‑oriented and places great value on her appearance. She feels at home in the fast‑paced world of fashion and trends. By achieving a slimmer figure, she hopes to strengthen her self‑confidence. For Laura, weight‑loss injections represent a modern and effective solution that can be easily integrated into her daily routine. However, she is concerned about whether she will be able to handle the long‑term costs of injection therapy.
Pre‑ and post‑GLP‑1 therapy with formoline L112 EXTRA
Klaus (65) suffers from several health conditions that are exacerbated by his excess weight, including osteoarthritis of the knee joints, sleep apnoea, chronic venous insufficiency and elevated cholesterol levels. His primary goal is to alleviate his symptoms and improve his overall health. He is looking for a medically sound therapy that supports weight loss and has a positive effect on his comorbidities. He is seriously considering weight‑loss injections but remains open to alternative treatment options.
CASE REPORT FROM CLINICAL PRACTICE
Weight development with tirzepatide and formoline L112
In a 57‑year‑old female patient with metabolic syndrome, obesity, type 2 diabetes, and depressive symptoms following weight gain (from 68 kg to 98 kg), measures aimed at weight reduction led to only limited success. It was only the combination of tirzepatide and formoline L112 that enabled a weight loss of 12 kg within three months, allowing tirzepatide to be discontinued. With continued use of formoline L112 and accompanying physical activity, no weight regain occurred; instead, an additional reduction of 10 kg was achieved. At the same time, physical performance improved and the depressive symptoms subsided.¹
formoline L112 EXTRA
Think beyond weight‑loss injections with us – to support your patients holistically in weight management.
Why formoline L112 EXTRA?
Post‑GLP‑1: helps counteract the yo‑yo effect
More cost‑effective for long‑term use
No injections required (oral administration)2
Pre‑GLP‑1: suitable as an entry therapy for patients with overweight who are undecided
High tolerability (purely physical mode of action, non‑systemic)2
Clinically relevant efficacy3
CLINICAL EVIDENCE
Studies3–5 show for polyglucosamine L112 (PG L112):
Binding of up to 66 % of dietary fats in the gastrointestinal tract and reduction of lipid absorption4
Significantly greater weight reduction with PG L112 vs placebo (≥ 50 % greater weight loss after 12 months)3
Reduction in waist circumference (~13 cm) and visceral fat3
Marked improvement of metabolic syndrome5
Weight reduction
Significantly greater weight reduction with PG L112 vs placebo (≥ 50% greater weight loss after 12 months)3
Reduction of visceral fat
Reduction in waist circumference (~13 cm) and visceral fat3
Improvement of blood parameters
Marked improvement of blood parameters3
Weight reduction
Significantly greater weight reduction with PG L112 vs placebo (≥ 50% greater weight loss after 12 months)3
Reduction of visceral fat
Reduction in waist circumference (~13 cm) and visceral fat3
Improvement of blood parameters
Marked improvement of blood parameters3
EXPERTS CONFIRM:
FORMOLINE L112 EXTRA COMPLEMENTS GLP‑1
Long‑term observations show that polyglucosamine L112 EXTRA can, after an initial weight reduction, help maintain the achieved weight over many years or even continue to improve it.
Dr Wolfgang Grebe
After weight loss achieved with GLP‑1 receptor agonists, formoline L112 EXTRA provides valuable support in preventing renewed weight gain and in securing long‑term treatment success.
Dr Wolfgang Grebe
In combination with a lifestyle change, formoline L112 EXTRA makes it easier to transition into a more active daily routine and can help support a stable target weight over the long term.
Dr Wolfgang Grebe
FAQ
Practical experience
formoline L112 is taken orally twice daily as two tablets with the main meals with the highest fat content.²
formoline L112 EXTRA is very well tolerated. The product acts purely physically and is not absorbed through the intestinal wall.2
formoline L112 EXTRA can be taken long term.6
Practice Updates
Stay Informed